PARLODEL Capsule (2018)
Βιβλιογραφική αναφορά
Για την προβολή της πλήρους καταχώρησης απαιτείται συνδρομή σε ισχύ.
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή
Περιεχόμενα
Name of the medicinal product
PARLODEL 5mg Capsules.
Qualitative and quantitative composition
Active substance: Ergotaman-3', 6', 18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl-5'-(2-methylpropyl)-, (5alpha)-mono-methanesulphonate. Each capsule contains 5.735mg of bromocriptine mesilate (equivalent ...
Pharmaceutical form
Light blue and white opaque hard gelatine capsules imprinted with 5 MG on the capsule body.
Therapeutic indications
Hyperprolactinaemia The treatment of hyperprolactinaemia in men and women with hypogonadism and/or galactorrhoea. Menstrual cycle disorders and female infertility Amenorrhoea and oligomenorrhoea, with ...
Posology and method of administration
PARLODEL should always be taken with food. A number of disparate conditions are amenable to treatment with PARLODEL and for this reason the recommended dosage regimens are variable. In most indications, ...
Contraindications
Hypersensitivity to bromocriptine or to any of the excipients of PARLODEL (see Section 2 Qualitative and Quantitative composition and Section 6.1 List of excipients) or to other ergot alkaloids. Bromocriptine ...
Special warnings and precautions for use
PARLODEL is contraindicated for use in the suppression of lactation or other non-life threatening indications in patients with severe coronary artery disease, or symptoms and/or a history of serious mental ...
Interaction with other medicinal products and other forms of interaction
Tolerance to PARLODEL may be reduced by alcohol. Caution is required in patients who are on concomitant therapy with, or have recently been treated with drugs that can alter blood pressure. Although there ...
Fertility, pregnancy and lactation
Pregnancy If pregnancy occurs it is generally advisable to withdraw PARLODEL after the first missed menstrual period. Rapid expansion of pituitary tumours sometimes occurs during pregnancy and this may ...
Effects on ability to drive and use machines
Hypotensive reactions may be disturbing in some patients during the first few days of treatment and particular care should be exercised when driving vehicles or operating machinery. Patients being treated ...
Undesirable effects
The occurrence of side-effects can be minimised by gradual introduction of the dose or a dose reduction followed by a more gradual titration. If necessary, initial nausea and/or vomiting may be reduced ...
Overdose
Signs and Symptoms Overdosage with PARLODEL is likely to result in vomiting and other symptoms which could be due to over stimulation of dopaminergic receptors and might include nausea, dizziness, hypotension, ...
Pharmacodynamic properties
Pharmacotherapeutic group: Dopamine agonist (ATC code: N04BC01) Prolactin inhibitor (ATC code: G02CB01) PARLODEL, active ingredient bromocriptine, is an inhibitor of prolactin secretion and a stimulator ...
Pharmacokinetic properties
Following oral administration, PARLODEL (bromocriptine) is rapidly and well absorbed. Peak plasma levels are reached within 1-3 hours. An oral dose of 5mg of bromocriptine results in a C<sub>max</sub> ...
Preclinical safety data
Pre-clinical data for PARLODEL (bromocriptine) reveal no special hazard for humans based on conventional studies of single and repeat dose toxicity, genotoxicity, mutagenicity, carcinogenic potential or ...
List of excipients
Capsule Content: Silica, colloidal anhydrous Magnesium stearate Maleic acid Maize starch Lactose monohydrate Capsule Shell: Indigo carmine (E132) Titanium dioxide (E171) Gelatin Printing Ink: Shellac (E904) ...
Incompatibilities
None.
Shelf life
<u>Opaque white PV/PVDC blister strip:</u> 24 months. <u>Amber glass bottle:</u> 36 months.
Special precautions for storage
<u>Amber glass bottle:</u> Store below 30°C. Store in the original package in order to protect from light. <u>Opaque white PV/PVDC blister strip:</u> Store below 25°C. Store in the original package in ...
Nature and contents of container
Opaque white PV/PVDC blister strip containing 30 PARLODEL 5mg capsules. Amber glass bottle with a tamper resistant closure containing 100 PARLODEL 5mg capsules. Not all pack sizes will be marketed.
Special precautions for disposal and other handling
No special requirements.
Marketing authorization holder
Mylan Products Ltd, Station Close, Potters Bar, Hertfordshire, EN6 1TL, United Kingdom
Marketing authorization number(s)
PL 46302/0138
Date of first authorization / renewal of the authorization
09 October 1981 / 27 October 1997
Date of revision of the text
27/02/2018
Πηγαίο έγγραφο
Το πηγαίο έγγραφο για αυτήν την βιβλιογραφική αναφορά είναι διαθέσιμο προς μεταφόρτωση: